The genetic and biochemical basis of Omenn syndrome

Sandro Santagata, Anna Villa, Cristina Sobacchi, Patricia Cortes, Paolo Vezzoni

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Omenn syndrome (OS) is a peculiar, autosomal recessive severe combined immunodeficiency (SCID) associated with early-onset, generalized, exudative erythrodermia; lymphoadenopathy; hepato- and splenomegaly; hypereosinophilia; elevated serum IgE; and normal to high activated, yet non-functional, oligoclonal T cells. Recent investigations have shown that the primum movens of all these puzzling features lies in a defect of the lymphoid-specific V(D)] recombination process. Abnormalities in both alleles of either Rag-1 or -2 genes are found in all OS patients. At variance with T-B- SCID, whose Rag mutations represent null alleles, OS mutations maintain a residual recombination activity, allowing limited T-cell receptor gene rearrangements to occur in the thymus. The gene rearrangements are subsequently expanded in the periphery after environmental antigen exposure. Missense mutations detected in OS have been examined in a number of biochemical assays and have contributed to dissect the various functional domains of both Rag-1 and Rag-2 proteins. The examination of a set of mutations occurring in the Rag-1 N-terminal portion has demonstrated that this region play's a fundamental role in vivo. The elucidation of the molecular basis of OS has allowed us to perform early prenatal diagnosis and could be the basis for trials of in utero bone marrow transplantation or gene therapy approaches.

Original languageEnglish
Pages (from-to)64-74
Number of pages11
JournalImmunological Reviews
Volume178
Publication statusPublished - 2000

Fingerprint

Severe Combined Immunodeficiency
Molecular Biology
Mutation
Genetic Recombination
Alleles
T-Lymphocyte Gene Rearrangement
T-Cell Receptor Genes
Hepatomegaly
Gene Rearrangement
Splenomegaly
Environmental Exposure
Missense Mutation
Prenatal Diagnosis
Bone Marrow Transplantation
Genetic Therapy
Thymus Gland
Immunoglobulin E
Early Diagnosis
T-Lymphocytes
Antigens

ASJC Scopus subject areas

  • Immunology

Cite this

The genetic and biochemical basis of Omenn syndrome. / Santagata, Sandro; Villa, Anna; Sobacchi, Cristina; Cortes, Patricia; Vezzoni, Paolo.

In: Immunological Reviews, Vol. 178, 2000, p. 64-74.

Research output: Contribution to journalArticle

@article{d779813e8f6a445da7a1d53527d2b2a0,
title = "The genetic and biochemical basis of Omenn syndrome",
abstract = "Omenn syndrome (OS) is a peculiar, autosomal recessive severe combined immunodeficiency (SCID) associated with early-onset, generalized, exudative erythrodermia; lymphoadenopathy; hepato- and splenomegaly; hypereosinophilia; elevated serum IgE; and normal to high activated, yet non-functional, oligoclonal T cells. Recent investigations have shown that the primum movens of all these puzzling features lies in a defect of the lymphoid-specific V(D)] recombination process. Abnormalities in both alleles of either Rag-1 or -2 genes are found in all OS patients. At variance with T-B- SCID, whose Rag mutations represent null alleles, OS mutations maintain a residual recombination activity, allowing limited T-cell receptor gene rearrangements to occur in the thymus. The gene rearrangements are subsequently expanded in the periphery after environmental antigen exposure. Missense mutations detected in OS have been examined in a number of biochemical assays and have contributed to dissect the various functional domains of both Rag-1 and Rag-2 proteins. The examination of a set of mutations occurring in the Rag-1 N-terminal portion has demonstrated that this region play's a fundamental role in vivo. The elucidation of the molecular basis of OS has allowed us to perform early prenatal diagnosis and could be the basis for trials of in utero bone marrow transplantation or gene therapy approaches.",
author = "Sandro Santagata and Anna Villa and Cristina Sobacchi and Patricia Cortes and Paolo Vezzoni",
year = "2000",
language = "English",
volume = "178",
pages = "64--74",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The genetic and biochemical basis of Omenn syndrome

AU - Santagata, Sandro

AU - Villa, Anna

AU - Sobacchi, Cristina

AU - Cortes, Patricia

AU - Vezzoni, Paolo

PY - 2000

Y1 - 2000

N2 - Omenn syndrome (OS) is a peculiar, autosomal recessive severe combined immunodeficiency (SCID) associated with early-onset, generalized, exudative erythrodermia; lymphoadenopathy; hepato- and splenomegaly; hypereosinophilia; elevated serum IgE; and normal to high activated, yet non-functional, oligoclonal T cells. Recent investigations have shown that the primum movens of all these puzzling features lies in a defect of the lymphoid-specific V(D)] recombination process. Abnormalities in both alleles of either Rag-1 or -2 genes are found in all OS patients. At variance with T-B- SCID, whose Rag mutations represent null alleles, OS mutations maintain a residual recombination activity, allowing limited T-cell receptor gene rearrangements to occur in the thymus. The gene rearrangements are subsequently expanded in the periphery after environmental antigen exposure. Missense mutations detected in OS have been examined in a number of biochemical assays and have contributed to dissect the various functional domains of both Rag-1 and Rag-2 proteins. The examination of a set of mutations occurring in the Rag-1 N-terminal portion has demonstrated that this region play's a fundamental role in vivo. The elucidation of the molecular basis of OS has allowed us to perform early prenatal diagnosis and could be the basis for trials of in utero bone marrow transplantation or gene therapy approaches.

AB - Omenn syndrome (OS) is a peculiar, autosomal recessive severe combined immunodeficiency (SCID) associated with early-onset, generalized, exudative erythrodermia; lymphoadenopathy; hepato- and splenomegaly; hypereosinophilia; elevated serum IgE; and normal to high activated, yet non-functional, oligoclonal T cells. Recent investigations have shown that the primum movens of all these puzzling features lies in a defect of the lymphoid-specific V(D)] recombination process. Abnormalities in both alleles of either Rag-1 or -2 genes are found in all OS patients. At variance with T-B- SCID, whose Rag mutations represent null alleles, OS mutations maintain a residual recombination activity, allowing limited T-cell receptor gene rearrangements to occur in the thymus. The gene rearrangements are subsequently expanded in the periphery after environmental antigen exposure. Missense mutations detected in OS have been examined in a number of biochemical assays and have contributed to dissect the various functional domains of both Rag-1 and Rag-2 proteins. The examination of a set of mutations occurring in the Rag-1 N-terminal portion has demonstrated that this region play's a fundamental role in vivo. The elucidation of the molecular basis of OS has allowed us to perform early prenatal diagnosis and could be the basis for trials of in utero bone marrow transplantation or gene therapy approaches.

UR - http://www.scopus.com/inward/record.url?scp=0034501028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034501028&partnerID=8YFLogxK

M3 - Article

C2 - 11213808

AN - SCOPUS:0034501028

VL - 178

SP - 64

EP - 74

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

ER -